The ongoing battle to control opioid addiction has not gone well. Many of the government’s efforts have been medically and scientifically flawed and unproductive. Some have even been counterproductive. Public policy is in disarray. A Feb. 1 article in the Journal of the American Medical Association concluded, “Under current conditions, the opioid overdose crisis is… Read More »
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive fentanyl spray as opioid addiction was spiraling into a public health crisis, a U.S. prosecutor said on Monday. John Kapoor, the billionaire founder of Insys Therapeutics Inc, arrives at the federal courthouse for the first… Read More »
Two years ago, U.S. Centers for Disease Control (CDC) data revealed a sudden drop in life expectancy in the U.S. for 2015.1,2 It was the first decline in 20 years. The trend continued in 2016,3 and the latest data for 20174 show the downward trend continuing for the third year in a row, which makes… Read More »
Download PDF New Links on MedlinePlus
The FDA announced on Friday that it would side with its advisory panel by approving a new opioid drug, called Dsuvia, despite the country already being in the midst of an opioid crisis and critics voicing concerns about the safety of the drug. FDA Commissioner Dr. Scott Gottlieb defended the FDA’s decision to approve the… Read More »